Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609830 · ClinicalTrials.gov registry record · NA
GIOP Prevention Among People With Rheumatoid Arthritis
A NA study of Rheumatoid Arthritis and Osteoporosis, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
- 1
- Study location
NCT00609830 is a NA study of Rheumatoid Arthritis and Osteoporosis that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 273 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00609830, a NA study of Rheumatoid Arthritis and Osteoporosis, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
- 1
- Study location
Study Summary
The ultimate objective of the proposed research is to improve the health-related quality of life of individuals with rheumatoid arthritis by reducing their risk of developing osteoporosis secondary to glucocorticoid therapy. The study has four specific aims. Specific Aim 1: To obtain descriptive information concerning patients' knowledge, beliefs and behaviors with respect to osteoporosis and osteoporosis prevention. Specific Aim 2: To identify factors that discriminate among patients in different stages of change with respect to each behavior of interest. Specific Aim 3: To compare the effects of tailored versus generic educational materials on patient adherence to the ACR Guidelines for the Prevention of Glucocorticoid-Induced Osteoporosis. Specific Aim 4: To determine if the effects of tailored educational materials are enhanced by concurrent feedback of information concerning patients' behavioral risk factor status to their physicians.
Conditions Studied
Interventions
- BEHAVIORAL Tailored Materials
- BEHAVIORAL Tailored Materials Plus Physician Feedback
- BEHAVIORAL Generic Materials
- BEHAVIORAL No Information
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill School of Pharmacy - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2001-07 |
| Est. Completion | 2006-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609830
The ClinicalTrials.gov registry entry for NCT00609830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 4 interventions - of which Tailored Materials is the first listed.
NCT00609830 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00609830 about?
NCT00609830 is a clinical study titled "GIOP Prevention Among People With Rheumatoid Arthritis". The ultimate objective of the proposed research is to improve the health-related quality of life of individuals with rheumatoid arthritis by reducing their risk of developing osteoporosis secondary to glucocorticoid therapy. The study has four specific aims. Specific Aim 1: To obtain descriptive in...
What is the current status of trial NCT00609830?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2001-07. Estimated completion is 2006-02.
What conditions does trial NCT00609830 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoporosis.
What interventions are being tested in trial NCT00609830?
The interventions under investigation include: Tailored Materials (BEHAVIORAL), Tailored Materials Plus Physician Feedback (BEHAVIORAL), Generic Materials (BEHAVIORAL), No Information (BEHAVIORAL).
Who is sponsoring clinical trial NCT00609830?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00609830 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.